ResMed (RMD) has quietly drifted lower over the past week, but the stock is still up this year, which raises a straightforward question for investors: is this dip an opportunity or a warning? See our ...

Resmed believes its artificial intelligence-powered approach to personalizing the settings of its connected CPAP machines can lead to better sleep for people with obstructive apnea. Now the FDA has ...

Resmed (NYSE: RMD) + announced today that it received FDA clearance for its Smart Comfort personalized therapy offering. San Diego–based Resmed calls Smart Comfort (which was submitted to the FDA as ...

SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced it has ...

Technology uses real-world sleep data and machine learning to help people with sleep apnea start and stay on therapy SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the ...

Fractus, a company specializing in geometry-based antenna technology and IP licensing, has filed a patent infringement suit against respiratory leader ResMed. The complaint was filed in the United ...

SAN DIEGO – Resmed CEO Mick Farrell addressed the latest potential threats to the CPAP therapy market during a recent webcast: The resurgence of Medicare’s competitive bidding program and the ...

A CPAP machine is a medical device often recommended to folks who have sleep apnea or other disruptive sleep conditions. Wearers place a mask over their nose and mouth to deliver a continuous stream ...

April 23 (Reuters) - Resmed (RMD.N), opens new tab beat Wall Street estimates for third-quarter profit on Wednesday, driven by demand for its sleep apnea devices used to manage the common sleep ...

Researchers found evidence for reduced risk of dying from all causes and cardiovascular disease when OSA patients were treated with CPAP versus non-CPAP users. Patients with obstructive sleep apnea ...

ResMed reported $1.28 billion in revenue and $2.43 EPS, driven by strong demand for AirSense 11 and effective cost management. Rising awareness of sleep apnea, aided by wearable devices like Apple ...

Few observers think of CPAP machines as common fare where the med-tech patent wars are concerned, but Resmed Corp. recently came away with a win in litigation that resulted in the nullification of the ...